Products

AnovaOS
Anova Enterprises
Drug Discovery & Research
AnovaOS is an AI-based patient matching solution for clinical trials that leverages AI to match molecular, demographic, and clinical history data against eligibility criteria from active trials. It connects patients to over 200,000 open clinical trials with high-confidence eligibility matching.

See all 1 product →

About Anova Enterprises

Anova Enterprises is a healthcare AI company focused on transforming and accelerating clinical trials. Their AnovaOS™ platform is designed to streamline the clinical research process, reducing the time and cost associated with bringing new investigational products to market. The platform aims to improve patient access to experimental treatments and facilitate a patient-focused development approach grounded in precision medicine.

For physicians, AnovaOS™ provides an integrated research network that connects them with 15,000 sponsors, 130,000 active studies, 15,000 investigational products, and over 40,000 research sites and 100,000 investigators. This allows treating physicians and research staff to efficiently match patients to promising new treatments, secure access, and quickly enroll them in clinical trials or compassionate use programs. The platform also offers direct access to key decision-makers at manufacturers for just-in-time access to investigational products. AnovaOS™ is a catalyst for accelerating the development of complex treatments across various therapeutic areas, including oncology, infectious disease, neurology, immunology, cardiology, and rare diseases. In December 2025, Anova launched an AI-enabled patient matching solution as part of its global just-in-time research network, which is available at no cost to participating research sites. This solution leverages AI and proprietary algorithms to accurately identify patients who meet trial eligibility criteria by cross-referencing demographic, molecular, and clinical history data against over 200,000 ongoing trials.

Focus Areas

Clinical trial acceleration patient matching compassionate use programs precision medicine oncology infectious disease neurology immunology cardiology rare disease

Business Intelligence

Key InvestorsAurora Capital Partners, FFL Partners, Golub Capital BDC, Golub Capital BDC 4, Golub Capital Private Credit Fund BDC, Golub Capital Private Income Funds
PartnershipsOPN Healthcare, Korea Orphan & Essential Drug Center (KODC), Mary Crowley Cancer Research, University of California at San Francisco (UCSF), University of California at San Diego (UCSD), University of Southern California (USC), Denovo Biopharma, Dizal (Jiangsu) Pharmaceuticals
AcquisitionsCorlexia Clinical Services
TechnologyAnovaOS™ (cloud-native, AI-powered operating system, SaaS-based)
FDA ClearancesUnknown cleared products (estimated)

What Physicians Need to Know

Clinical Trial Acceleration
Anova Enterprises utilizes its AnovaOSu2122 technology platform to significantly reduce the time and cost associated with bringing new investigational products to market. They achieve this through standardization and automation of clinical trials, compassionate use programs, and investigator-initiated trials.
Patient Matching
AnovaOSu2122 offers an AI-based patient matching solution that connects individuals to active studies and investigational products. This system leverages algorithms and AI to match molecular, demographic, and clinical history data against trial eligibility criteria, enabling rapid enrollment for targeted or rare patient populations.
Compassionate Use Programs
Anova facilitates access to promising investigational products for patients with serious or life-threatening conditions who are unable to participate in clinical trials. Their platform streamlines the application process for compassionate use, providing direct access to manufacturers and supporting the generation of real-world evidence.
Precision Medicine
Anova is dedicated to realizing the promise of precision medicine by helping patients access the right investigational treatments wherever they receive care. Their platform supports matching patients to highly targeted therapies and streamlining recruitment for rare populations.
Therapeutic Area Specialization
AnovaOSu2122 acts as a catalyst for accelerating the development of complex treatments across various therapeutic areas, including oncology, infectious disease, neurology, immunology, and cardiology, as well as rare diseases.
Integrated Research Network
AnovaOSu2122 provides an integrated research network comprising over 15,000 sponsors, 130,000 active studies, 15,000 investigational products, 44,000+ research sites, and 100,000+ investigators. This network brings the global clinical research environment together for every treating physician.
Real-World Data & Registry
Anova has launched a global clinical registry to collect real-world data on patient diagnoses, treatments, and outcomes for complex and rare diseases. This registry aims to inform clinical decision-making, support post-market surveillance, and aid in data-driven study design.
Physician Tip

For physicians, Anova Enterprises offers a powerful platform, AnovaOSu2122, that acts as an on-demand research network. This allows you to efficiently match your patients to any of the 130,000+ active clinical trials or 15,000+ investigational products. You can streamline the process of securing access and enrolling patients in clinical trials or compassionate use programs, often in the time it takes to start the next line of therapy. The platform provides direct access to key decision-makers at manufacturers for just-in-time access to investigational products. Anova also offers consultancy services for clinical development and technical services for data integration and advanced analytics. Their AI-enabled patient matching solution is available free at participating research sites.

AnovaOSu2122 is designed to integrate into current clinical workflows, supporting the screening of subjects for studies and providing real-time updates on criteria changes and available studies. The platform connects sponsors to a vast network of research sites and facilitates collaboration among all participants in the clinical research process.

Products by Anova Enterprises

1 product in the directory

AnovaOS
Anova Enterprises
Drug Discovery & Research
AnovaOS is an AI-based patient matching solution for clinical trials that leverages AI to match molecular, demographic, and clinical history data against eligibility criteria from active trials. It connects patients to over 200,000 open clinical trials with high-confidence eligibility matching.

What the Web Says

Anova Enterprises appears to be a name used by several distinct companies, primarily Anova Culinary (known for sous vide devices), AnovaOS (a clinical trial platform), Anova Health Care System, and Anova Consulting Group. Reviews for Anova Culinary products are generally positive regarding quality and functionality, though recent changes to app connectivity and customer service have drawn criticism. AnovaOS and Anova Health Care System receive positive feedback for their respective services and work environments, while Anova Consulting Group is noted for its consultative approach.

Overall: Mixed

Strengths

  • High product quality and consistency (Anova Culinary)
  • User-friendly platforms and seamless user experience (AnovaOS, Anova Culinary, Anova Health Care System)
  • Strong customer service for product replacements (Anova Culinary, historically)
  • Supportive and caring work environment (Anova Education & Behavioral Consultation, Anova Health Care System)
  • Effective in accelerating clinical trials and improving patient access (AnovaOS)
  • Flexible scheduling for caregivers (Anova Health Care System)

Limitations

  • Recent decline in Anova Culinary customer service and product quality
  • Subscription model and disabled app functionality for older Anova Culinary devices
  • High price point for Anova Culinary products
  • Outdated dashboard and reporting tools (Anova Consulting Group)
  • Some negative experiences with Anova Fertility regarding patient care and billing
  • Weak management and dangerous work conditions reported at ANOVA Furnishings

Based on reviews from: The Nutrition Insider, Capterra, Anova Culinary Customer Reviews & Ratings, Reddit, Anova Enterprises, Elion Health, Indeed, Great Place To Work, G2

Last updated: 2026-09-24

Videos

News, demos, and interviews about Anova Enterprises.

Loading videos...

Videos load interactively. If none appear, search YouTube for Anova Enterprises →

View all on YouTube

Press & Coverage

Anova Enterprises
Anova Expands Platform with Launch of Next-Generation eTMF Solution for Sponsors, CROs, and Research Sites
Anova Enterprises launched its next-generation electronic Trial Master File (eTMF) platform, a unified study document management solution designed to streamline clinical trial operations and improve collaboration between sponsors, CROs, and research sites.
2026-07
Anova Enterprises
Anova and Nouveau Biosciences Announce Partnership to Deliver Clinical Trials of Kromastat for the Treatment of Relapsed or Refractory Cutaneous and Peripheral T-Cell Lymphoma
Anova Enterprises partnered with Nouveau Biosciences, Inc. to conduct cancer-focused clinical trials for Kromastat, a lead asset targeting relapsed or refractory cutaneous and peripheral T-cell lymphoma.
2026-07
Anova Enterprises
Five Hundredth Urology Research Site Joins Anova's Global Urology Research Network
Anova announced the expansion of its virtual urology research network, reaching a milestone of 500 onboarded sites, facilitated by its AnovaOS platform to enhance collaboration and patient access.
2026-07
Anova Enterprises
Anova Launches Free AI-Enabled Clinical Trial Matching Solution as Part of a Global Just-in-Time Research Network
Anova launched a new AI-enabled patient matching solution, part of a global just-in-time research network, to accelerate clinical trial enrollment by connecting patients with suitable studies.
2025-12
BioSpace
Anova Today Announced the Enrollment of 550+ Patients at 50+ Sites in Six Months for a Single Study
Anova completed the enrollment of over 550 patients across more than 50 sites for a single study in just six months, leveraging its AnovaOSu2122 Platform to significantly reduce traditional enrollment timelines.
2025-12
Business Wire
Anova Launches Global Clinical Registry to Accelerate Research and Access to Promising New Treatments
Anova Enterprises launched a global clinical registry, compliant with 21 CFR Part 11, to provide real-world evidence, enhance administrative efficiency in research, and support data-driven study design.
2025-09
Anova Enterprises
Anova Announces First Patient Enrolled to Phase 1/2a Study of DB107 for the Treatment of High-Grade Gliomas
Anova announced the enrollment of the first two patients in a Phase 1/2a clinical trial for DB107, an investigational treatment for high-grade gliomas, aiming to confirm its clinical benefit when added to standard-of-care.
2025-03
GlobeNewswire
NeOnc Technologies Engages Anova Enterprises to Pursue Pediatric Brain Tumor Indication and FDA Fast-Track Status for NEO100
NeOnc Technologies expanded its engagement with Anova Enterprises to pursue a pediatric indication for NEO100, a therapeutic for pediatric high-grade gliomas, and to prepare for FDA Fast-Track and Rare Pediatric designations.
2023-03

Frequently Asked Questions

Anova Enterprises accelerates clinical trials and patient matching through its AnovaOSu2122 technology platform. This platform provides an integrated research network that connects sponsors, active studies, investigational products, research sites, and investigators. It leverages AI and algorithms to match patients' molecular, demographic, and clinical history data against trial eligibility criteria, streamlining enrollment in areas like oncology, infectious disease, neurology, immunology, cardiology, and rare diseases.
Anova Enterprises facilitates compassionate use programs by enabling physicians and research staff to rapidly match patients to investigational products and secure access. They offer a streamlined and automated application process for compassionate use. Anova emphasizes ethical research and regulatory compliance, with their approach validated by regulators, and they assist in generating data from these programs that can support regulatory submissions.
Anova Enterprises primarily offers the AnovaOSu2122 technology platform. This platform functions as a global just-in-time research network, providing tools for patient matching, study activation and enrollment, regulatory compliance, and data capture. It also includes a global clinical registry to accelerate research and provide real-world evidence.
While specific pricing for their clinical trial acceleration platform isn't explicitly detailed for healthcare providers, Anova's AI-based patient matching solution is available free at participating research sites. For general Anova software, pricing plans range from u00a30.5 to u00a33.75 per user per month, with free trial and free versions available. Anova offers support for its AnovaOSu2122 platform via email and provides consulting services for clinical development and technical aspects.
Anova Enterprises partners with various entities, including biopharmaceutical companies, academic medical centers, and community oncology networks like OPN Healthcare and Mary Crowley Cancer Research, to expand clinical research programs and patient access. Anova was acquired by Aurora Capital Partners, a private equity firm, in January 2026, indicating a new chapter for the company with a focus on accelerating product innovation and global expansion.

Related Companies

Google DeepMind is a leading artificial intelligence (AI) research laboratory, a subsidiary of Alphabet Inc., dedicated to developing advanced AI systems to benefit humanity. The company focuses on creating general-purpose AI that can learn and solve complex problems, drawing inspiration from neuroscience and machine learning. Their work spans various fields, including healthcare, scientific discovery, and […]

TalkToMedi is a Canadian healthcare AI company that has developed a clinical-grade voice AI platform called MEDI. This platform is designed to automate patient communication and administrative tasks for medical clinics, including family medicine, specialty clinics, allied health, and physiotherapy. MEDI handles high-volume patient calls, automating appointment inquiries, booking, rescheduling, and cancellations based on the […]

Menaela is an AI-first practice management system designed for solo practitioners, small private clinics, and clinic owners. It integrates patient communication, scheduling, CRM, and medical documentation into a single platform, aiming to replace multiple disconnected tools and bots. The system features an AI practice manager that understands natural-language requests, utilizes real clinic data, and performs […]

Avie (avie.me) is a healthcare AI company that focuses on providing a next-generation, whole-person health approach, bridging the gap between clinical and holistic care. The company connects individuals with providers and clinicians who can support their unique physical, emotional, cognitive, and logistical needs. Avie emphasizes fusing physical and mental best practices to enhance overall health, […]

Saile is a physician-founded healthcare technology company that addresses critical inefficiencies in healthcare staffing and credentialing. Their AI-powered platform acts as a “universal credential passport” for physicians, centralizing and managing all medical licenses, certifications, and CME credits in one secure, portable vault. This system aims to significantly reduce the administrative burden and delays associated with […]

Data Capture Experts (DCE) is an Australian-based healthcare AI company that is at the forefront of digital health transformation. They specialize in developing and implementing digital health platforms that integrate data, technology, and human-centered design to create intuitive and connected healthcare systems. Their flagship platform, DC2Vue, is designed to go beyond traditional Electronic Medical Records […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.